Cannabist Co Holdings Inc. (CBSTF) is a U.S.-focused cannabis company reporting $458.7M in 2024 revenue but facing persistent net losses of $105.1M and a total debt burden exceeding $700M.
An investor might consider CBSTF for its demonstrated path toward reduced annual losses, suggesting a turning point in operational profitability is near. The company's substantial asset base and established market presence offer significant upside potential if regulatory reforms reduce compliance costs or expand legal markets. Recovery of working capital and divestiture proceeds could provide the necessary liquidity to service debt and fund growth initiatives.
The stock carries extreme risk due to negative shareholders' equity of -$30.1M and a total liability burden of $726.2M that threatens solvency in any down market. Consistent operating cash flow deficits of over $23M indicate the business cannot yet fund its own growth without continuous external financing or dilution. The significant decline in revenue year-over-year highlights vulnerability to industry consolidation and potential inability to cover interest payments on long-term debt.
Cannabist Co Holdings Inc. (CBSTF) operates within the cannabis sector, generating revenue through cultivation, processing, and distribution of cannabis products primarily in regulated U.S. markets. The company's financial profile reflects a capital-intensive business model with significant operating expenses and inventory levels typical of the industry. Despite recent revenue contraction, the firm continues to manage its substantial debt load and negative cash flows from operations.
Management has successfully narrowed the net loss from -$174.3M in 2023 to -$105.1M in 2024, indicating an operational efficiency improvement despite a decline in total revenue. However, the company remains cash-burn negative with operating cash flow at -$23.4M and a massive accumulated other comprehensive loss of -$1.19B impacting equity. The reduction in revenue from $511.6M in 2022 to $458.7M in 2024 suggests potential market saturation or pricing pressure that management must address.
The cannabis industry is characterized by high capital expenditure requirements for cultivation facilities and regulatory compliance costs that vary significantly by jurisdiction. Market competition is intensifying as new players enter regulated states, leading to margin compression and pressure on inventory values across the sector. Industry leaders are focusing on vertical integration to control supply chains and mitigate the risks associated with price volatility.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $511.6M | $511.3M | $458.7M |
| Cost of Revenue | $310.4M | $331.4M | $290.4M |
| Gross Profit | $201.2M | $180.0M | $168.3M |
| Operating Expenses | $617.5M | $285.2M | $190.6M |
| Operating Income | $-416.2M | $-105.2M | $-22.3M |
| G&A | $277.3M | $199.6M | $188.3M |
| Stock-Based Comp | $27.9M | $5.5M | $-1.0M |
| D&A | $84.8M | $62.7M | $49.0M |
| Depreciation | $32.1M | $34.3M | $29.0M |
| Amortization | $44.5M | — | $11.4M |
| Other OpEx | $340.1M | $85.6M | $2.2M |
| Non-Operating Income | $-16.5M | $-63.7M | $-39.5M |
| Pre-Tax Income | $-432.7M | $-168.9M | $-61.8M |
| Income Tax | $-11.2M | $5.4M | $43.3M |
| Continuing Ops | $-421.5M | $-174.3M | $-105.1M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-421.5M | $-174.3M | $-105.1M |
| Minority Interest | $-5.5M | $1.4M | $760.0K |
| Net to Common | $-416.0M | $-175.7M | $-105.9M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $237.2M | $187.5M | $195.0M |
| Accounts Receivable | $10.1M | $15.6M | $21.7M |
| Inventory | $127.9M | $111.6M | $94.5M |
| Prepaid Expenses | $21.9M | $22.8M | $11.8M |
| Other Current Assets | $77.2M | $37.5M | $67.0M |
| Long-Term Assets | $757.5M | $635.6M | $501.2M |
| PP&E (Net) | $358.0M | $298.5M | $228.4M |
| Intangibles | — | — | $51.2M |
| Goodwill | $19.3M | $0 | — |
| Operating Leases | $174.5M | $181.8M | $124.7M |
| Other LT Assets | $205.8M | $155.3M | $96.8M |
| Total Assets | $994.7M | $823.1M | $696.2M |
| Current Liabilities | $203.1M | $160.0M | $228.7M |
| Accounts Payable | $23.8M | $29.8M | $41.1M |
| Current Debt | $47.3M | $5.9M | $52.5M |
| Current Leases | $6.8M | $9.7M | $7.4M |
| Deferred Revenue | — | — | $919.0K |
| Taxes Payable | $34.0M | $47.4M | $87.3M |
| Other Current Liab | $26.7M | $8.6M | $6.6M |
| Long-Term Liabilities | $584.7M | $597.7M | $497.5M |
| Long-Term Debt | $281.7M | $297.5M | $249.5M |
| LT Operating Leases | $174.3M | $182.0M | $126.2M |
| Other LT Liab | $128.7M | $118.2M | $121.8M |
| Total Liabilities | $787.8M | $757.8M | $726.2M |
| Shareholders' Equity | $206.9M | $65.4M | $-30.1M |
| AOCI | $-904.0M | $-1.08B | $-1.19B |
| Total L&E | $994.7M | $823.1M | $696.2M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-421.5M | $-174.3M | $-105.1M |
| Non-Cash Adjustments | $308.5M | $182.5M | $-476.0K |
| Working Capital Changes | $1.6M | $-713.0K | $82.2M |
| Cash from Operations | $-111.4M | $7.5M | $-23.4M |
| Capital Expenditures | $72.7M | $10.0M | $5.8M |
| Cash from Investing | $-75.3M | $-3.5M | $31.0M |
| Cash from Financing | $153.7M | $-14.1M | $-9.0M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $-33.0M | $-10.2M | $-1.4M |
| Beginning Cash | $82.5M | $49.5M | $39.3M |
| Ending Cash | $49.5M | $39.3M | $37.9M |
Cannabist Co Holdings Inc. derives its revenue primarily from the sale of cannabis flower, concentrates, and edibles through various distribution channels including retail dispensaries and wholesale partnerships. The financial data indicates operations are heavily influenced by changes in inventory valuation and cost of revenue fluctuations common in the volatile cannabis supply chain.
The company faces severe liquidity risk with current liabilities of $228.7M exceeding current assets and a negative shareholders' equity position. Regulatory uncertainty across different U.S. states poses a threat to ongoing operations and potential expansion plans. Persistent operating losses and high debt service requirements could lead to covenant violations or forced asset sales if cash flow does not improve.
The company possesses a large-scale production footprint allowing for economies of scale in cultivation that can lower per-unit costs over time. Strategic location assets provide access to key high-consumption markets, creating a barrier to entry for smaller competitors. Established relationships with major retail dispensary networks offer stability in sales channels despite regulatory headwinds.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.